Cited by 190Alzheimer's disease research and treatmentsAutophagy in Disease and TherapyUbiquitin and proteasome pathways

The Ubiquitin-Proteasome System and the Autophagic-Lysosomal System in Alzheimer Disease

Open access
Ihara, Y., Morishima-Kawashima, M., Nixon, R.·2012·Cold Spring Harbor Perspectives in Medicine

Abstract

As neurons age, their survival depends on eliminating a growing burden of damaged, potentially toxic proteins and organelles-a capability that declines owing to aging and disease factors. Here, we review the two proteolytic systems principally responsible for protein quality control in neurons and their important contributions to Alzheimer disease pathogenesis. In the first section, the discovery of paired helical filament ubiquitination is described as a backdrop for discussing the importance of the ubiquitin-proteasome system in Alzheimer disease. In the second section, we review the prominent involvement of the lysosomal system beginning with pathological endosomal-lysosomal activation and signaling at the very earliest stages of Alzheimer disease followed by the progressive failure of autophagy. These abnormalities, which result in part from Alzheimer-related genes acting directly on these lysosomal pathways, contribute to the development of each of the Alzheimer neuropathological hallmarks and represent a promising therapeutic target.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/cshperspect.a006361

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dysregulation in many autophagic/lysosomal pathways occurs in the context of AD.

    “a number of studies reporting dysregulation in many autophagic/lysosomal pathways in the context of AD [234,235]”

    From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [234]

  • Increased pRb is present in the cytoplasm of neurons in the substantia nigra of PD patients compared to age-matched controls.

    “Increased pRb, another important regulator of cell-cycle progression, was reported in the cytoplasm of neurons in the substantia nigra of PD patients compared to age-matched controls [234].”

    From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [234]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 217 · Cited by 190

Research works printed but not linked: 5

  1. Cherra SJ 3rd, Dagda RK, Chu CT. 2010. Review: Autophagy and neurodegeneration: Survival at a cost? Neuropathol Appl Neurobiol 36: 125-132.
  2. Larsen KE, Sulzer D. 2002. Autophagy in neurons: A review. Histol Histopathol 17: 897-908.
  3. Lee S, Saito Y, Nixon RA. 2011b. Primary lysosomal dys- function causes cargo-specific deficits of axonal trans- port leading to Alzheimer's-like neuritic dystrophy. Autophagy 7: in press.
  4. Lim JP, Gleeson PA. 2011. Macropinocytosis: An endocytic pathway for internalising large gulps. Immunol Cell Biol doi: 10.1038/icb.2011. · DOI
  5. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL. 2007. FoxO3 coordinately acti- vates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6: 472-483. Cite this article as Cold Spring Harb Perspect Med 2012;2:a006361 4, 2012 2012; doi: 10.1101/cshperspect.a006361 originally published online April Cold Spring Harb Perspect Med

Authors
Ihara, Y., Morishima-Kawashima, M., & Nixon, R.
Affiliations
  • Doshisha University (JP)
  • Nathan Kline Institute for Psychiatric Research (US)
Corresponding author
Ihara, Y.
Venue
Cold Spring Harbor Perspectives in Medicine
Published
2012-04-04
Volume
2
Issue
8
Pages
a006361-a006361
ISSN
2157-1422 (ISSN-L)
OpenAlex
W2165152085
Cited by
190
References
217
Citations by year
2026: 8 · 2025: 15 · 2024: 6 · 2023: 11 · 2022: 10 · 2021: 14 · 2020: 12 · 2019: 9 · 2018: 13 · 2017: 21 · 2016: 16 · 2015: 16 · 2014: 16 · 2013: 19 · 2012: 3
Type
posted content
Language
en
Open access
Locations
  • Cold Spring Harbor Perspectives in Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Tokyo
  • National Institute on Aging
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
ubiquitin-proteasome system, autophagy, lysosomal system, Alzheimer's disease, protein quality control, paired helical filaments, ubiquitination, neurodegeneration, therapeutic target
MeSH terms
Alzheimer Disease, Amyloid, Animals, Autophagy, Disease Models, Animal, Humans, Lysosomes, Nerve Degeneration, Neurons, Endosomes, Amyloid beta-Peptides, Neurofibrillary Tangles, tau Proteins, Cellular Senescence, Disease Progression, Ubiquitin, Proteasome Endopeptidase Complex, Mice, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review